NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q1 2024 vs. Q4 2023
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 18 | 11 | −7 |
| Shares | 1.64M | 1.44M | −196.8K (−12.0%) |
| Value | $4.91M | $15.9M | +$11.0M (+223.6%) |
New holders (3)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GTS Securities LLC | 121,150 | $1.34M | 0.04% |
| Monashee Investment Management LLC | 31,189 | $344.3K | 0.04% |
| CIBC Private Wealth Group, LLC | 1,000 | $11.3K | 0.00% |
Sold out (10)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ensign Peak Advisors, Inc | 150,000 | $469.5K |
| ADAR1 Capital Management, LLC | 82,857 | $259.3K |
| Westchester Capital Management, LLC | 31,189 | $97.6K |
| Walleye Capital LLC | 22,658 | $70.9K |
| Susquehanna International Group, LLP | 18,319 | $57.3K |
| PEAK6 Investments LLC | 17,000 | $53.2K |
| Walleye Trading LLC | 13,084 | $41.0K |
| Clear Street LLC | 8,993 | $28.1K |
| Cutler Group LP | 4,960 | $15.0K |
| EcoR1 Capital, LLC | 66,665 | – |